Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 98 of 159 for:    Urinary Tract Infections | Recruiting, Not yet recruiting, Available Studies | "Communicable Diseases"

Antibiotic Stewardship in Infectious Disease Departement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03636711
Recruitment Status : Not yet recruiting
First Posted : August 17, 2018
Last Update Posted : August 17, 2018
Sponsor:
Information provided by (Responsible Party):
Assistance Publique Hopitaux De Marseille

Brief Summary:

Consensual antibiotic protocols have been developed and validated locally by infectious disease specialists, internists and emergency physicians, in order to encourage their compliance. A preliminary study was conducted from June 2015 to February 2016, including 622 patients admitted to the emergency department for infectious syndrome such as /

  • Pneumoniae
  • Urinary tract infection
  • Cellulitis
  • Meningitis
  • Malaria
  • Febrile neutropenia
  • Febrile acute diarrhea
  • Fever back to the tropics
  • Angina
  • sexually transmitted infection This prospective study will observe and analyze the adherence of prescribers to these protocols. With description of patients who benefited or not the antibiotic protocol, according to a syndromic approach and analysis of the causes of non-adherence to the protocols. In order to limit the length of stay and reduce the cost of hospitalization..

Condition or disease Intervention/treatment
Infectious Disease Other: antibiotic protocol, according to a syndromic approach

Detailed Description:

Consensual antibiotic protocols have been developed and validated locally by infectious disease specialists, internists and emergency physicians, in order to encourage their compliance. A preliminary study was conducted from June 2015 (setting up protocols) to February 2016, including 622 patients admitted to the emergency department for infectious syndrome such as /

  • Pneumoniae
  • Urinary tract infection
  • Cellulitis
  • Meningitis
  • Malaria
  • Febrile neutropenia
  • Febrile acute diarrhea
  • Fever back to the tropics
  • Angina
  • sexually transmitted infection This prospective study will observe and analyze the adherence of prescribers to these protocols. With description of patients who benefited or not the antibiotic protocol, according to a syndromic approach and analysis of the causes of non-adherence to the protocols. In order to limit the length of stay and reduce the cost of hospitalization..

Layout table for study information
Study Type : Observational [Patient Registry]
Estimated Enrollment : 2000 participants
Observational Model: Cohort
Time Perspective: Prospective
Target Follow-Up Duration: 10 Days
Official Title: Adherence to Anti-infectious Treatment Protocols in Emergencies and Short-term Hospitalization at the Infectious Disease Department"
Estimated Study Start Date : September 2018
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : January 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Antibiotics

Group/Cohort Intervention/treatment
experimental group
• Patient admitted to emergency for infectious syndrome Description of antibiotic protocol, according to a syndromic approach will be performed
Other: antibiotic protocol, according to a syndromic approach
Description of patients who benefited or not the antibiotic protocol, according to a syndromic approach and analysis of the causes of non-adherence to the protocols




Primary Outcome Measures :
  1. List of Antibiotic treatment [ Time Frame: up to 12 weeks ]

    Description of the prescribed antibiotic treatment depending of infectious syndrome: name, duration for each treatment during hospitalization

    Data will be collected in the medical files:

    • date of introduction of antibiotic treatment
    • withdrawal dates
    • stop dates
    • antibiotic classes

  2. Adverse events [ Time Frame: up to 12 weeks ]

    Description of the cause of non adherence to antibiotic treatment initiates at hospital admission of antibiotherapy:

    Data will be collected in the medical files of patients:

    events leading to withdrawal or stop treatment (insufficiency renal, allergic reaction ... etc) date of events aggravation or recovery




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients who present a infectious syndrom
Criteria

Inclusion Criteria:

  • Patient admitted to emergency for infectious syndrome
  • Patient > 18 years old.
  • Patient who accept to have his medical records reviewed for research.

Exclusion Criteria:

  • Patient < 18 years old.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03636711


Contacts
Layout table for location contacts
Contact: PHILIPPE PAROLA, MD +33 491387235 Philippe.PAROLA@ap-hm.fr
Contact: CECILE LAVOUTE, PHD +33 491381878 cecile.lavoute@ap-hm.fr

Locations
Layout table for location information
France
Assistance Publique Des Hopitaux de Marseille Not yet recruiting
Marseille, Paca, France, 13005
Contact: CECILE LAVOUTE, PHD    +33 491381878    cecile.lavoute@ap-hm.fr   
Sponsors and Collaborators
Assistance Publique Hopitaux De Marseille
Investigators
Layout table for investigator information
Study Director: EMILIE GARRIDO PRADALIE APHM

Additional Information:

Layout table for additonal information
Responsible Party: Assistance Publique Hopitaux De Marseille
ClinicalTrials.gov Identifier: NCT03636711     History of Changes
Other Study ID Numbers: 2018-24
First Posted: August 17, 2018    Key Record Dates
Last Update Posted: August 17, 2018
Last Verified: August 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Communicable Diseases
Infection
Anti-Bacterial Agents
Antibiotics, Antitubercular
Anti-Infective Agents
Antitubercular Agents